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Abstract
Background: Apolipoprotein B-100 (apo B-100) stands as one of the largest proteins in humans.
Its large size of 4536 amino acids hampers the production of X-ray diffraction quality crystals and
hinders in-solution NMR analysis, and thus necessitates a domain-based approach for the structural
characterization of the multi-domain full-length apo B.
Results: The structure of apo B-17 (the N-terminal 17% of apolipoprotein B-100) was predicted
by homology modeling based on the structure of the N-terminal domain of lipovitellin (LV), a
protein that shares not only sequence similarity with B17, but also a functional aspect of lipid
binding and transport. The model structure was first induced to accommodate the six disulfide
bonds found in that region, and then optimized using simulated annealing.
Conclusion: The content of secondary structural elements in this model structure correlates well
with the reported data from other biophysical probes. The overall topology of the model conforms
with the structural outline corresponding to the apo B-17 domain as seen in the EM representation
of the complete LDL structure.
Background
Atherosclerosis is a complex disease that has been linked
to many risk factors, including hyperlipidemia, dyslipi-
demia, high blood pressure, and endothelial dysfunction
[1]. Oxidative modification to the small low-density lipo-
protein (LDL) has been dubbed the central event that ini-
tiates and propagates coronary artery diseases [2,3], and
therefore, LDL is considered a major risk factor for athero-
sclerosis [4]. It was also shown that systemic inflamma-
tory mechanisms may underlie the pathogenesis of
atherosclerosis [5-7]. However, the specific structural
interactions implicated in these mechanisms have not yet
been elucidated.
Apolipoprotein B-100 (apo B) is the sole protein compo-
nent of LDL [8]; however, its large size (4536 a.a.) and the
limitation of current experimental techniques require that
the structures of its multiple domains be analyzed sepa-
rately [9,10]. Biochemical [10], calorimetric [11], compu-
tational [12-15], and spectroscopic [16] approaches were
used to probe the domain arrangement and characteriza-
tion of the protein, but no molecular structure has ever
been assigned to any of the different domains. These tech-
niques, however, helped in the understanding of the over-
all arrangement of apo B on the LDL particle and the
interactions that the various secondary structures have
with both the lipid and aqueous phases, and in the ability
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The sequence alignment of B17 with the N-terminus of LV Figure 1
The sequence alignment of B17 with the N-terminus of LV. The figure also shows the different structural domains 
(Cyan boxes are for the βC-sheet and the magenta boxes are for the α-domain. The underlined stretch indicates the region of 
no electron density in the template structure.BMC Biochemistry 2007, 8:12 http://www.biomedcentral.com/1471-2091/8/12
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to genetically engineer protein truncations that corre-
spond to these various domains [17-20].
In this report, we describe a model structure for apo B-17
that was modeled by homology, taking the crystal struc-
ture of lipovitellin (LV) [21-23] as a template. LV – coded
1LSH in the Protein Data Bank (PDB) repository – shares
more than 30% sequence similarity with the first 782 a.a.
of apo B (the N-terminal 17% of the full-length
sequence), a region that is rich in disulfide bonds [24,25],
essential for the secretion of the protein from hepatic cells
[17], and behaves like an independent globular protein
[19,20]. It seemed logical to try to characterize the struc-
ture of B17 using homology modeling as a starting step
towards the study of the whole structure of apo B-100.
Results and discussion
LDL has been termed as the agent provocateur of atheroscle-
rosis. Since ApoB-100 is the sole protein component of
LDL, it is expected that it plays an important role in the
atherogeneity of the lipid particle. The huge size of the
polypeptide hinders standard structural characterization
approaches, and necessitates that it be studied in pieces,
possibly correlating with the domain organization previ-
ously characterized by biochemical studies.
We present here a comprehensive model structure for the
N-terminal domain of apolipoprotein B-100 based on the
lipovitellin crystal structure. LV, an egg yolk lipoprotein,
has four β-sheet domains, labeled according to their
sequence order as βC, βA, βB, and βD, and one α-helical
domain labeled α, situated between the C- and A-sheets
[21-23]. Lipids are transported in a pocket bounded by
the three sheets βB, βA, and βD. The interaction between
lipids and the other two domains, the C-sheet and the α-
domain, is absent and minimal, respectively. Several
rounds of multiple sequence alignments revealed that the
sequence of B17 aligns best with the N-terminal C-sheet,
the α-domain and a part of the A-sheet of LV (Figure 1),
with about 25% sequence identity registered and an addi-
tional 15% of residue similarity obtained.
Among the six disulfide bonds identified in B17 [24,25],
only one pair of disulfide bonded cysteins is conserved in
LV, and therefore, it was a challenge to see if the other
pairs fall – or can be made to fall – within bonding prox-
imities without steric hindrances. Indeed, the first model
had the sulfur atoms of three pairs of neighboring cysteins
less than 4 Å apart, whereas the rest of the cystein pairs
had their sulfur atoms 5–10 Å away. To bond these latter
ones, the cysteine residues were brought to bonding dis-
tances (4 Å) through a series of step wise automated or
directed energy minimization (Figure 2).
The secondary structure prediction of the unstructured section Figure 3
The secondary structure prediction of the unstructured section. The secondary structure of this C-terminus of B17 
was separately modeled, and the results from PredictProtein are shown, where the H's underneath the sequence indicate heli-
cal regions.
The six disulfide bonds found in B17 Figure 2
The six disulfide bonds found in B17. The cysteine resi-
dues are rendered in ball-and-stick representation. The sulfur 
atoms are colored in yellow.BMC Biochemistry 2007, 8:12 http://www.biomedcentral.com/1471-2091/8/12
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One disulfide pair came within binding distance after a
series of minimization runs, and two pairs approached
binding distance through directed (constrained) minimi-
zation, adding up to 6 disulfide bridges. However, those
that were subject to constrained minimization were
located within flexible loops at the surface of the protein,
and thus did not cause the overall fold to change. Minimi-
zation was done in a step-wise fashion in order to explore
bonding space between the sulfur groups without distort-
ing secondary formations. Finally, a molecular dynamics
simulation at 25–27 degrees Celsius was performed on
the B17 molecule to allow its side chains to explore
allowed conformational space.
A 78-residue stretch in the A-sheet of LV has no resolving
electron density, and therefore, no coordinate assign-
ments in the crystal structure. The correspondingly
aligned amino acids in B17 (residues 706 – 782) had to
be modeled separately. The secondary structures of this
stretch were predicted using a variety of algorithms,
including the Chou-Fasman algorithm [26], the PROF
methods of PredictProtein [27,28], and the SPDBV
modality of Deep View. All of these modalities suggested
an-all-helical structure of the stretch, with a helical con-
tent around 65 % (Figure 3) and a reliability index
approaching 90%. Several rounds of energy minimization
and simulation – first in vacuum and later in water as a
solvent – were performed allowing the previously-
unstructured region to adopt a stable fold while its ends
were fixed in space at coordinates corresponding to the
crystal structure amino acids immediately preceding and
succeeding the beginning and end residues in the primary
sequence, respectively. Then, using the LIGATE modality
in HOMOLOGY, the structure of this part was pinned to
the corresponding extremities in the LV-modeled B17,
and the energy of the whole molecule was minimized
again (Figure 4).
It should be noted here that a well-ordered structure is to
be expected in this stretch owing to the fact that earlier
biophysical studies suggested the presence of secondary
structural elements that cannot be accounted for by what
is reported in the crystal structure of LV only [19,20]. The
secondary structural content in this complete model cor-
relates excellently with the data reported previously using
those biophysical probes. The structure also confirms the
exposure of several coil-bound histidine residues that may
be implicated in some helical rearrangement upon their
protonation due to a slight decrease in the solvent pH
[19,20]. The accessibility of these residues to the aqueous
solvent was tested (Table 1), and their protonation upon
the decrease in pH was confirmed.
The structure of LV has been reported to contain a com-
pletely buried salt bridge formed between R547 and E574
[21], which ties together the two "helical sheets" in the α-
domain, thereby increasing the stability of the local fold.
A careful inspection of the B17 model structure revealed
that a very similar salt bridge is formed between K530 and
E557, which align – sequentially – with the above-men-
tioned residues in LV. Moreover, the solvent accessibility
analysis illustrates that the involved side chains are well
shielded form the aqueous medium and can therefore
account for an extra stability in the α-domain of B17 that
has been previously reported [19,20].
Table 1: Solvent accessibility for the buried salt bridge.
Solvent Accessibility Surface Area (Å2)
Residue Atom Before Solvation After Solvation
K530 NZ 75.20 0.89
E557 OE2 1.54 0.00
Solvent accessibility surface areas for individual atoms calculated according to the hydration states of the corresponding atoms
The structure of B17 modeled after the N-terminus of LV Figure 4
The structure of B17 modeled after the N-terminus 
of LV. β-strands are colored blue, whereas α-helices are 
colored red. Arrows and labels indicate the beginning and 
end of the 78-aa stretch modeled independent of the LV 
structure.BMC Biochemistry 2007, 8:12 http://www.biomedcentral.com/1471-2091/8/12
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Electron microscopy studies of intact LDL particles
[29,30] showed that the N-terminus of apo B has a knob-
shaped electron density with dimensions 30 – 45 Å. These
dimensions approximate perfectly with the β-domain in
the B17 model (Figure 5). These dimensions, along with
the positions of the disulfide bonds and the buried, con-
served salt bridge in the helical region, give credibility to
the model. The lipid pocket surface accessibility – for
potential lipid recruitment – towards the inside of the α-
domain also makes the structure trustworthy.
A comprehensive structure validation test was carried out
to check the physical elements of the model. Bond angles
were found to deviate normally from the reported mean
standard values [31]. Moreover, the RMS Z-score for bond
angles in this model structure is within 9 % change with
respect to that in the template structure. Bond lengths
were found to have normal variability. The contact dis-
tances of all atom pairs have been checked. Among the 31
reported abnormally short interatomic distances in B17
(more than 200 in the corresponding LV template), 23 are
either representations of hydrogen bonds or predictions
of atoms with B-factors higher than 80, indicating that the
atoms potentially implicated in these bumps are not there
anyway. The evaluation of the model torsion angles did
indeed show some unusual residues; however, the two
amino acids, P623 and T651, with Z-scores around -3.0
(the worrying limit), actually fall in the region joining the
α-domain with the C-terminus of the protein. P623 is at
the end of a β-strand and T651 is the second of a two-res-
idue turn between two strands as well, all three of these
strands are involved in a mini sheet between the helical
region and the C-terminus (Figure 6), and, therefore, the
slight increase in their torsional energy is compensated by
the overall fold stability. Finally, the Ramachandran plot
of the backbone psi-phi angles of the B17 model showed
comparative results to those obtained from the crystal
structure of LV (Figure 7).
Conclusion
This model provides further insight into the structural
basis for the functional attributes of B-17, and constitutes
a step towards the full elucidation of the multi-domain
Fold versus angle stability Figure 6
Fold versus angle stability: P623 and T651, with Z-scores 
around -3.0, fall in turns involved in a mini sheet between the 
helical region and the C-terminus. The elevated torsion 
energy is compensated by an overall fold energy reduction.
The spatial dimensions of the β-domain of B17 Figure 5
The spatial dimensions of the β-domain of B17. (A) 
Side view and (B) top view of the N-terminus of B17 with the 
corresponding dimensional values. These values correlate 
perfectly with the "knob" structure seen on the LDL particle 
and mapped to the N-terminus of B100.BMC Biochemistry 2007, 8:12 http://www.biomedcentral.com/1471-2091/8/12
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The Ramachandran plots of B17 and LV Figure 7
The Ramachandran plots of B17 and LV. More than 97% of the backbone angle-pairs in B17 fall within the favorable 
regions, whereas 2.3% fall within the additionally allowed regions, and less than 1% is in the disallowed regions. This is very sim-
ilar to the data from the LV system (98% in the favorable regions, 1% in the additionally allowed regions, and 1% in the disal-
lowed regions).BMC Biochemistry 2007, 8:12 http://www.biomedcentral.com/1471-2091/8/12
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structure of full-length Apo B-100. While the current struc-
ture ensures the globular topology of the domain and its
poor lipidation state, as it does not show lipid binding
pockets, the biological implications of this protein – inde-
pendent of its role in apo B-100 – remain to be tested in
vitro and, later, in vivo, since B17 is not a naturally occur-
ring plasma apolipoprotein. Knowing the importance of
this domain in the secretion and assembly of the full-
length apo B-100, we anticipate that the current structure
and subsequent physiological experiments will assist in
the development of novel drugs for the treatment of and
protection against diseases correlated with elevated blood
LDL.
Methods
Molecular modeling
Sequence alignment
Multiple sequence alignments were done using BLAST
[32] and the alignment module of the Discovery Studio
suite (Accelrys Inc., Discovery Studio 1.5, San Diego:
Accelrys Inc., 2004)
Structure prediction
The structure of B17 (residues 1–704) was modeled using
MODELLER [33] of HOMOLOGY in insight II (Accelrys
Inc., Insight Modeling Environment, Release 2000.1, San
Diego: Accelrys Inc., 2002), based on the crystal structure
of lipovitellin (LV), an egg yolk protein that shares over
30% sequence homology (in over 700 amino acid over-
lap) with B17. The secondary structure of the unstructured
region was predicted using the Chou-Fasman Algorithm
[26], the PROF methods [27,28] and the Deep View
modality [34]. The calculation was performed using the
Accelrys SeqWeb server of the GCG Wisconsin Package.
Simulation
Energy calculations
EC's were performed using DISCOVER (Accelrys Inc.,
CDiscover Molecular Simulator, Release 2000.1, San
Diego: Accelrys Inc., 2002) and CHARMm (Version c28b)
[35] modules in Insight II. Energy minimizations were
performed using the Steepest Descent method followed
by Conjugate Gradients.
Molecular dynamics
MD Simulations were carried out with periodic boundary
conditions using a cubic box (of appropriate size), in the
Insight II package. Solvent water molecules were repre-
sented by the three-site TIP3P water model [36], in the
NVT ensemble.
Force fields
Calculations were performed using the DISCOVER force-
fields CVFF and CFF91. The CHARMm force-field used in
the solvation simulation was CHARMm27.
Analysis
Solvent accessibility
Solvent Accessible Surface Area (SASA) was calculated for
individual atoms using the Structural Biology at NIH
server (Structools), with a probe radius of 1.4 Å [37].
Potential maps
Solvation energy and hydrophobic interactions were cal-
culated using the Delphi module in Insight II (Accelrys
Inc., Delphi Module, Release 2000.1, San Diego: Accelrys
Inc., 2002), using the CFF91 force-field. Potential maps
were constructed using a grid. The dielectric value was
assigned as 4 for the protein and 80 for the solvent.
Structure validation
Structure validation tests were carried out using the PRO-
CHECK [38] and WHATIF [39] modalities. Calculated val-
ues were referenced to the reported mean standard values
[31].
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